Mahmut BAŞOĞLU, Bülent AYDINLI, Gürkan ÖZTÜRK, M. İlhan YILDIRGAN, S. Selçuk ATAMANALP

Ogilvie's syndrome:Presentation of 15 cases

Giriş: Ogilvie Sendromu, mekanik bir tıkanıklık olmaksızın kolonun akut yaygın dilatasyonu ile karakterizedir. Yöntem ve Gereç: Ogilvie Sendromlu 15 hastanın kayıtları, cins, yaş, eşlik eden problemler, belirti süresi, belirtiler, bulgular, tedavi, morbidite, mortalite ve nüks yönünden retrospektif olarak gözden geçirildi.Bulgular: Sekiz hasta erkek, 7 hasta bayan olup yaş ortalaması 49,9 idi (32-76 arası). Beş hastada medikal problemler varken, 4 hasta ameliyat geçirmişti ve 2 hastada da yanık vardı. Ortalama belirti süresi 2,9 gündü (1-7 arası). En sık karşılaşılan belirtiler karın ağrısı ve şişkinlik iken, en sık görülen bulgular karında hassasiyet ve distansiyondu. Düz karın grafilerinde ortalama çekum çapı 10,0 cm idi. (7-13 arası). Başlangıç tedavisi bütün hastalarda konservatifti. Beş hasta intravenöz neostigmin ile tedavi edildi ve bunların 4’ünde tam açılma sağlandı (% 80,0). Fleksibıl kolonoskopik dekompresyon 9 hastaya uygulandı, başarı % 88,9 ve nüks % 12,5 oranında görüldü. Dört hasta cerrahi olarak tüp çekostomi ile tedavi edildi. Bu seride büyük bir komplikasyon görülmedi, fakat yanıklı 1 hasta kaybedildi (% 6,7).Sonuç: Ogilvie Sendromu’nda başlangıç tedavisi konservatiftir ve neostigmine tedavisi genellikle başarılıdır. Dekompresyon kolonoskopisi güvenle ve başarıyla kullanılabilir. Cerrahi tedavi, kolonoskopi başarısız olduğunda ya da çekal iskemi, nekroz veya perforasyon şüphesi varlığında kullanılır.

Ogilvie sendromu:Onbeş olgunun sunumu

Background: Ogilvie’s syndrome is characterized by acute, massive colonic dilatation, without any mechanical obstruction. Methods: The records of 15 patients with Ogilvie’s syndrome were retrospectively reviewed with respect to gender, age, associated problems, symptom duration, symptoms, signs, treatment, morbidity, mortality, and recurrence. Results: Mean age of the patients (8 male, 7 female) was 49.9 years (range: 32-76 years). Among them, 5 had medical problems, while 4 patients had had abdominal surgery, and 2 patients had burns. Mean symptom duration was 2.9 days (range: 1-7 days). The most common symptoms were abdominal pain and distention, while the most common signs were abdominal tenderness and distention. Mean cecal diameter was 10.0 cm (range: 7-13 cm) in plain abdominal X-ray films. The initial treatment was conservative in all patients; 5 were treated with intravenous neostigmine and complete resolution was achieved in 4 of them (80%). Flexible colonoscopic decompression was performed in 9 patients, with placement of a colonic tube; a success rate of 88.9% and a recurrence rate of 12.5% were noted. Tube cecostomy procedures were performed on 4 patients. No major complications were encountered in this series, but one patient with burns died (6.7%). Conclusions: The initial treatment of Ogilvie’s syndrome is conservative, and neostigmine treatment is generally successful. Decompression colonoscopy can be performed safely and successfully. Surgical treatment is performed when colonoscopy is unsuccessful, or when cecal ischemia, necrosis, or perforation is suspected.

PDF

___

1. Kodner IJ, Fry RD, Fleshman JW, Birnbaum EH, Read TE. Colon, rectum and anus. In: Schwartz SI, Shires GT, Daly JM, Fischer JE, Galloway AC, editors. Principles of Surgery, 7th ed. New York: McGraw Hill; 1999, p.1275.
2. Fink AS. Endoscopy. In: Zinner MJ, Schwartz SI, Ellis H, Arstley SW, McFadden DW, editors. Maingot’s Abdominal Operations, 10th ed. Stamford: Appleton and Lange; 1997, p.224.
3. Rolandelli RH. Diarrhea and constipation. In: Zinner MJ, Schwartz SI, Ellis H, Arstley SW, McFadden DW, editors. Maingot’s Abdominal Operations, 10th ed. Stamford: Appleton and Lange; 1997, p.347.
4. Saclarides TJ, Harrison J. Pseudo-obstruction (Ogilvie’s syndrome). In: Fazio VW, Church JM, Delaney CP, editors. Current Therapy in Colon and Rectal Surgery, 2nd ed. Philadelphia: Elsevier Mosby; 2005, p.321-326.
5. Delgado-Aros C, Camilleri M. Pseudo-obstruction in the critically ill. Best Prac Res Clin Gastroenterol 2003; 17: 427-444.
6. Senagore AJ. Ogilvie: I remember that name. Current Surgery 2001; 58: 345-349.
7. Rondeau M, Weber JC, Nodot I, Storck D. Etiology and prognosis of acute colonic pseudo-obstruction: a retrospective study in an internal medicine unit. Rev Med Interne 2001; 22: 536-541.
8. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999; 341: 137-141.
9. Strodel WE, Nostrant TT, Eckhauser FE, Dent TL. Therapeutic and diagnostic colonoscopy in nonobstructive colonic dilatation. Ann Surg 1983; 197: 416-421.
10. Aslan S, Bilge F, Aydinli B, Ocak T, Uzkeser M, Erdem AF et al. Amitraz: an unusual aetiology of Ogilvie’s syndrome. Hum Exp Toxicol 2005; 24: 481-483.
11. Jani PG. Acute colonic pseudo obstruction (Ogilvie’s syndrome): case report. East Afr Med J 2005; 82: 325-328.
12. Pokorny H, Plochl W, Soliman T, Herneth AM, Scharitzer M, Pokieser P, Berlakovich GA, Muhlbacher F. Acute colonic pseudo obstruction (Ogilvie’s syndrome) and pneumatosis intestinalis in a kidney recipient patient. Wiener Klinische Wochenschrift 2003; 115: 732-735.
13. Ould-Ahmed M, de Saint-Martin L, Ansart S, Renault A, Boles JM. Acute colonic pseudo obstruction (Ogilvie’s syndrome) in pneumococcal meningo-encephaliitis treated with neostigmine. Annales Francaises D Anesthesie et de Reanimation 2003; 22: 900-903.
14. Singh S, Nadgir A, Bryan RM. Post-cesarean section acute colonic pseudo-obstruction with spontaneous perforation. Int J Gynecol Obstet 2005; 89: 144-145.
15. Attarbashi S, Yadav Y, Ahmad G. Intestinal pseudoobstruction (Ogilvie’s syndrome) following cesarean delivery. Int J Gynecol Obstet 2006; 94: 133-134.
16. Rajiv M, Anil J, Prem N, Raj VV, Mustafa CP, Deepak S, Balakrishnan, V. Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo-obstruction: A prospective study. J Gastroenterol and Hepatol 2006; 21: 459- 461.
17. Kakarla A, Posnett H, Jain A, Ash A. Acute pseudo-obstruction of the colon (Ogilvie’s syndrome) following instrumental vaginal delivery. Int J Clin Pract 2006; 60: 1303-1305.
18. Fazel A, Verne GN. New solutions to an old problem: Acute colonic pseudo-obstruction. J Clin Gastroenterol 2005; 39: 17-20.
19. Pham TN, Comsan BC, Chu P, Savides TJ. Radiographic changes after colonoscopic decompression for acute pseudo-obstruction. Dis Colon Rectum 1999; 42: 1586-1591.
20. Grassi R, Cappabianca S, Porto A, Sacco M, Montemarano E, Quarantelli M, Di Mizio R, De Rosa R. Ogilvie’s syndrome (acute colonic pseudo-obstruction): review of the literature and report of 6 additional cases. Radiologia Medica 2005; 109: 370-375.
21. Wegener M, Borsch G. Acute colonic pseudo-obstruction (Ogilvie’s syndrome): Presentation of 14 our own cases and analysis of 1027 cases reported in the literature. Surg Endosc 1987; 1: 169- 174.
22. Chapman AH, McNamara M, Porter G. The acute contrast enema in suspected large bowel obstruction: value and technique. Clinical Radiology 1992; 46: 273-278.
23. Mongardini M, Schillaci F, Cola A, Fanello G, Benedetti F, Maturo A, Pappalardo G. Adhesion ileus in patient with previous diagnosis of Ogilvie’s syndrome. G Chir 2005; 26: 318-320.
24. Sgouros SN, Vlachogiannakos J, Vassiliades K, Bergele C, Stefanidis G, Nastos H, Avgerinos A, Mantides A. The effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudoobstruction after the resolution of colonic dilatation: a prospective, randomised, placebo-controlled trial. Gut 2006; 55: 638-642.
25. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Eng J Med 1999; 341: 137-141.
26. Di Giorgio R, Stanghellini V, Barbara G, Guerrini S, Lioce A, Vasina V, Tonini M, Cola B, Corinaldesi R, De Ponti F. Prokinetics in the treatment of acute intestinal pseudo-obstruction. Idrugs 2004; 7: 160-165.
27. Schermer CR, Hanosh JJ, Davis M, Pitcher DE. Ogilvie’s syndrome in the surgical patient: A new therapeutic modality. J Gastrointest Surg 1999; 3: 173-177.
28. Jones C, Mitre R, Cobb C, Frame K, Agrawal R, Brodmerkel GJ. Gastrografin as a primary treatment modality for Ogilvie’s syndrome. Gastroenterology 1996; 112: 756.
29. Lee JT, Taylor BM, Singleton BC. Epidural anesthesia for acute pseudo-obstruction of the colon (Ogilvie’s syndrome). Dis Colon Rectum 1988; 31: 686-691.
30. Mashour GA, Peterfreund RA. Spinal anesthesia and Ogilvie’s syndrome. J Clin Anesth 2005; 17: 122-123.
31. Catena F, Caira A, Ansaloni L, Calo G, De Bonis F, Agrusti S, D’Alessandro L, Taffurelli M. Ogilvie’s syndrome treatment. Acta Biomed Ateneo Parmense 2003; 74: 26-29.
32. Chevallier P, Marcy PY, Francois E, Peten EP, Motamedi JP, Padovani B, Bruneton JN. Controlled transperitoneal percutaneous cecostomy as a therapeutic alternative to the endoscopic decompression for Ogilvie’s syndrome. Am J Gastroenterol 2002; 97: 471-474.
33. Reverdy D, Gebhart M, Kothonidis K, Gallez J, De Becker D, Liberale G. Pseudo-colonic obstruction after lumbar spine surgery: a case report. Acta Orthop Belg 2006; 72: 769-771.
34. Lynch CR, Jones RG, Hilden K, Wills JC, Fang JC. Percutaneous endoscopic cecostomy in adults: a case series. Gastrointest Endosc 2006; 64: 279-282.